These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7674911)

  • 1. Obesity, insulin resistance, and its link to non-insulin-dependent diabetes mellitus.
    Walker M
    Metabolism; 1995 Sep; 44(9 Suppl 3):18-20. PubMed ID: 7674911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects.
    Miele C; Formisano P; Condorelli G; Caruso M; Oriente F; Andreozzi F; Tocchetti CG; Riccardi G; Beguinot F
    Diabetologia; 1997 Apr; 40(4):421-9. PubMed ID: 9112019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of obesity to insulin resistance in noninsulin-dependent diabetes mellitus.
    Perriello G; Misericordia P; Volpi E; Pampanelli S; Santeusanio F; Brunetti P; Bolli GB
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2464-9. PubMed ID: 7629243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity.
    Garvey WT; Maianu L; Huecksteadt TP; Birnbaum MJ; Molina JM; Ciaraldi TP
    J Clin Invest; 1991 Mar; 87(3):1072-81. PubMed ID: 1999488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin downregulates pyruvate dehydrogenase kinase (PDK) mRNA: potential mechanism contributing to increased lipid oxidation in insulin-resistant subjects.
    Majer M; Popov KM; Harris RA; Bogardus C; Prochazka M
    Mol Genet Metab; 1998 Oct; 65(2):181-6. PubMed ID: 9787110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Energy and substrate metabolism in obesity and postobese state.
    Tappy L; Felber JP; Jéquier E
    Diabetes Care; 1991 Dec; 14(12):1180-8. PubMed ID: 1773703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus.
    Groop LC; Saloranta C; Shank M; Bonadonna RC; Ferrannini E; DeFronzo RA
    J Clin Endocrinol Metab; 1991 Jan; 72(1):96-107. PubMed ID: 1986032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance in Pima Indians. A combined effect of genetic predisposition and obesity-related skeletal muscle cell hypertrophy.
    Lillioja S; Bogardus C
    Acta Med Scand Suppl; 1988; 723():103-19. PubMed ID: 3134799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo glucose metabolism in obese and type II diabetic subjects with or without hypertension.
    Bonora E; Bonadonna RC; Del Prato S; Gulli G; Solini A; Matsuda M; DeFronzo RA
    Diabetes; 1993 May; 42(5):764-72. PubMed ID: 8482434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular mechanisms of insulin resistance in non-insulin-dependent (type II) diabetes.
    Olefsky JM; Garvey WT; Henry RR; Brillon D; Matthaei S; Freidenberg GR
    Am J Med; 1988 Nov; 85(5A):86-105. PubMed ID: 3057897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermic effect of glucose in obese subjects with non-insulin-dependent diabetes mellitus.
    Ravussin E; Zawadzki JK
    Diabetes; 1987 Dec; 36(12):1441-7. PubMed ID: 3315790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-induced decline of plasma amino acid concentrations in obese subjects with and without non-insulin-dependent diabetes.
    Pijl H; Potter van Loon BJ; Toornvliet AC; Radder JK; Onkenhout W; Frölich M; Meinders AE
    Metabolism; 1994 May; 43(5):640-6. PubMed ID: 8177054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of free fatty acids in the insulin resistance of non-insulin-dependent diabetes].
    Girard J
    Diabete Metab; 1995 Apr; 21(2):79-88. PubMed ID: 7621976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-induced hexokinase II expression is reduced in obesity and NIDDM.
    Pendergrass M; Koval J; Vogt C; Yki-Jarvinen H; Iozzo P; Pipek R; Ardehali H; Printz R; Granner D; DeFronzo RA; Mandarino LJ
    Diabetes; 1998 Mar; 47(3):387-94. PubMed ID: 9519744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM.
    Mandarino LJ; Consoli A; Jain A; Kelley DE
    Am J Physiol; 1996 Mar; 270(3 Pt 1):E463-70. PubMed ID: 8638694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased rate of Cori cycle in obese subjects with NIDDM and effect of weight reduction.
    Zawadzki JK; Wolfe RR; Mott DM; Lillioja S; Howard BV; Bogardus C
    Diabetes; 1988 Feb; 37(2):154-9. PubMed ID: 3391340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects.
    Santomauro AT; Boden G; Silva ME; Rocha DM; Santos RF; Ursich MJ; Strassmann PG; Wajchenberg BL
    Diabetes; 1999 Sep; 48(9):1836-41. PubMed ID: 10480616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle.
    Kelley DE; Mintun MA; Watkins SC; Simoneau JA; Jadali F; Fredrickson A; Beattie J; Thériault R
    J Clin Invest; 1996 Jun; 97(12):2705-13. PubMed ID: 8675680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.